Search

Your search keyword '"Hervochon, Rémi"' showing total 8 results
Start Over Author "Hervochon, Rémi" Search Limiters Full Text
8 results on '"Hervochon, Rémi"'

1. “Neuro-Fiber Mapping”: An Original Concept of Spinal Cord Neural Network Spatial Targeting Using Live Electrostimulation Mapping to (Re-)Explore the Conus Medullaris Anatomy

Author

Rigoard, Philippe, primary, Moens, Maarten, additional, Goudman, Lisa, additional, Le Tutour, Tom, additional, Rochette, Michel, additional, Dany, Jonathan, additional, Et Talby, Mohamed, additional, Roulaud, Manuel, additional, Hervochon, Rémi, additional, Ounajim, Amine, additional, Nivole, Kévin, additional, David, Romain, additional, and Billot, Maxime, additional

Published
2023
Full Text
View/download PDF

2. Comprehensive management of paranasal sinus fungus balls A Young-IFOS consensus statement

Author

Saibene, Alberto Maria, Allevi, Fabiana, Calvo Henriquez, Christian, Dauby, Nicolas, Dondossola, Daniele, Hervochon, Rémi, Maza Solano, Juan Manuel, Sowerby, Leigh, Universidad de Sevilla. Departamento de Cirugía, and Universita degli Studi di Milano

Subjects
mycosis, computed tomography, endoscopy, maxillary sinus, guideline, antibiotics
Abstract

Background Paranasal sinus fungus balls (PSFB) are a common form of surgically treatable, noninvasive mycosis. To date, no guidelines have standardized PSFB treatment or management of difficult cases (eg, immunocompromised or fragile patients). The clinical consensus statement presented herein aims to provide a comprehensive management guide to PSFB based on current evidence. Methods A multidisciplinary, international panel of 19 specialists judged statements in 3 rounds of a modified Delphi method survey. Statements encompassed the following PSFB management issues: definition, diagnostic workup; treatment indications and modalities; and follow-up. Otolaryngologists, maxillofacial surgeons, infectious disease specialists, and transplant physicians were considered the target audience. Results Among the 23 statements, 7 reached strong consensus and 16 reached consensus. Consensus was reached on the definition, diagnosis, and treatment modalities for PSFB. Postoperative follow-up modalities and scenarios with bacterial superinfection were the most debated issues. Conclusion Until further data are available, these points provide a framework for the management of PSFB. Moreover, PSFB should be considered a noninvasive mycosis that is not necessarily symptomatic or related to odontogenic conditions. Although diagnosis may be incidental, endoscopy and single imaging (computed tomography or magnetic resonance imaging, with distinctive features) are required for diagnosis, whereas contrast medium would allow for differential diagnosis. Although treatment of PSFB should be considered mandatory before sinus augmentation and is recommended for symptomatic patients, immunosuppressed patients, or patients with planned immunosuppression, watchful waiting could be considered for asymptomatic patients with chronic rhinosinusitis who are provided with appropriate advice and assessment.

Published
2022

3. Comprehensive management of paranasal sinus fungus balls A Young-IFOS consensus statement

Author

Universidad de Sevilla. Departamento de Cirugía, Universita degli Studi di Milano, Saibene, Alberto Maria, Allevi, Fabiana, Calvo Henriquez, Christian, Dauby, Nicolas, Dondossola, Daniele, Hervochon, Rémi, Maza Solano, Juan Manuel, Sowerby, Leigh, Universidad de Sevilla. Departamento de Cirugía, Universita degli Studi di Milano, Saibene, Alberto Maria, Allevi, Fabiana, Calvo Henriquez, Christian, Dauby, Nicolas, Dondossola, Daniele, Hervochon, Rémi, Maza Solano, Juan Manuel, and Sowerby, Leigh

Abstract

Background Paranasal sinus fungus balls (PSFB) are a common form of surgically treatable, noninvasive mycosis. To date, no guidelines have standardized PSFB treatment or management of difficult cases (eg, immunocompromised or fragile patients). The clinical consensus statement presented herein aims to provide a comprehensive management guide to PSFB based on current evidence. Methods A multidisciplinary, international panel of 19 specialists judged statements in 3 rounds of a modified Delphi method survey. Statements encompassed the following PSFB management issues: definition, diagnostic workup; treatment indications and modalities; and follow-up. Otolaryngologists, maxillofacial surgeons, infectious disease specialists, and transplant physicians were considered the target audience. Results Among the 23 statements, 7 reached strong consensus and 16 reached consensus. Consensus was reached on the definition, diagnosis, and treatment modalities for PSFB. Postoperative follow-up modalities and scenarios with bacterial superinfection were the most debated issues. Conclusion Until further data are available, these points provide a framework for the management of PSFB. Moreover, PSFB should be considered a noninvasive mycosis that is not necessarily symptomatic or related to odontogenic conditions. Although diagnosis may be incidental, endoscopy and single imaging (computed tomography or magnetic resonance imaging, with distinctive features) are required for diagnosis, whereas contrast medium would allow for differential diagnosis. Although treatment of PSFB should be considered mandatory before sinus augmentation and is recommended for symptomatic patients, immunosuppressed patients, or patients with planned immunosuppression, watchful waiting could be considered for asymptomatic patients with chronic rhinosinusitis who are provided with appropriate advice and assessment.

Published
2022

5. Post-COVID-19 Kawasaki-Like Syndrome.

Author

Lechien, Jérôme R., Hervochon, Rémi, and Hans, Stéphane

Subjects
*MUCOCUTANEOUS lymph node syndrome diagnosis, *COVID-19, *MUCOCUTANEOUS lymph node syndrome, *SYMPTOMS
Abstract

A 42-year-old man was referred for a week history of severe dysphagia, odynophagia, fever (39 °C), fatigue, abdominal pain, pharyngeal swelling, and multiple neck lymphadenopathies. The medical history reported a mild form of COVID-19 one month ago. The biology reported an unspecified inflammatory syndrome. The patient developed peritonitis, myocarditis, and hepatitis. A myocardium biopsy was performed. A diagnosis of Kawasaki-like disease (KLD) was performed. The occurrence of KLD in adults is rare but has to be known by otolaryngologists regarding the otolaryngological clinical presentation that may precede the multiple organ failure. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

7. Computed Tomography Description of the Uncinate Process Angulation in Patients With Cystic Fibrosis and Comparison With Primary Ciliary Dyskinesia, Nasal Polyposis, and Controls

Author

Hervochon, Rémi, primary, Teissier, Natacha, additional, Blondeau, Jean-Robert, additional, Remus, Natacha, additional, Bassinet, Laurence, additional, Canoui-Poitrine, Florence, additional, Van Den Abbeele, Thierry, additional, and Prulière-Escabasse, Virginie, additional

Published
2019
Full Text
View/download PDF

8. Pain in Patients with Post Paralytic Hemifacial Spasm: Before, during and after Botulinum Toxin Injections.

Author

Wehrlin, Chloé, Picard, Diane, Tankéré, Frederic, Hervochon, Rémi, and Foirest, Claire

Subjects
BOTULINUM A toxins, BOTULINUM toxin, INJECTIONS, SPASMS, FACIAL paralysis, FACIAL pain
Abstract

It is well-established that botulinum toxin (BT) injections improve quality of life in patients with postparalytic hemifacial spasm. Nevertheless, injection-related pain and contracture-related pain have not yet been studied. The primary objective of our study was to evaluate injection-related pain in patients with facial palsy sequelae, and to compare the standard technique (syringe) with the Juvapen device. The secondary objective was to evaluate the improvement of contracture-related pain one month after BT injection. Methods: We conducted an observational, prospective, monocentric study based on 60 patients with facial palsy sequelae who received BT injections in our university ENT (ear, nose throat) department. There were 30 patients in the Juvapen group (J) and 30 in the standard technique group (ST). All patients completed Numerical Rating Scale (NRS) questionnaires immediately after the injections and one month later. Results: The average NRS score was 1.33/10 with Juvapen and 2.24/10 with the standard technique (p = 0.0058; Z = 2.75). In patients with contracture-related pain, the average NRS score was 3.53 before BT injection, and 0.41 one month after BT injection (p = 0.0001). Conclusions: Juvapen is a less-painful injection technique than the standard one. BT reduces contracture-related pain one month after injection. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results